Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC Contact Us Summary The aim of this study was to evaluate the safety of a novel dendritic cell (DC) vaccine pulsed with survivin and MUC1, silenced with suppressor of cytokine signaling 1 (SOCS1), and immune stimulated with flagellin for patients […]
Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers
Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers Contact Us Summary This study investigates the correlation of cytokines produced by Dendritic Cells with clinical outcomes in patients with diverse cancers. The results reveal, aDC injections were feasible and safe. Increased production of specific cytokines was correlated with […]
The combination of Dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors
The combination of Dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors Contact Us Summary The purpose of this study is to investigate the role of DC-CTL/CIK therapy and evaluate the changes of immune indicators and tumor serological markers.As a result The study demonstrated that DC-CTL/CIK therapy […]
Preparation of highly activated Natural Killer cells for advanced Lung cancer therapy
Preparation of highly activated Natural Killer cells for advanced Lung cancer therapy Contact Us Summary This study investigates the efficacy of highly activated Natural Killer (HANK) cell immunotherapy in patients with advanced lung cancer. As a result, these clinical observations demonstrated that NK cell is safe and efficient for advanced lung cancer therapy. Patients characteristics […]
Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma
Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma Contact Us Summary This study examines the effects of the treatment by atient-specific vaccines consisting of autologous dendritic cells loaded with antigens from irradiated cells from short-term autologous tumor cell lines, on patients with Metastatic Melanoma. The results show the association […]
Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients
Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients Contact Us Summary This study aims to investigate the efficacy of dendritic cell vaccination in metastatic uveal melanoma. The results suggest that Dendritic cell vaccination is feasible and safe in metastatic uveal melanoma. Dendritic Cell vaccination may be associated with longer than average […]
